Presidents Club Winner. Promoting and assisting with acquisition through buy and bill and specialty pharmacy the injectable, Xeomin, (incobotulinumtoxinA) for therapeutic use to Neurologist, Movement Disorder Specialist, Physiatrist, hospitals and educational institutions in Tennessee and Northern Alabama.

Circle of Excellence winner Responsible for the sales of Rytary and Zomig nasal spray to Neurologist and Movement Disorder Specialist in Middle Tennessee and parts of Kentucky. Including Vanderbilt and St. Thomas medical

Boehringer-Ingelheim, Nashville, TN - 2012 - Present2015- Selected for the Diabetes Franchise, responsible for launching Glyxambi to a regional ranking of #1 and Synjardy to a national ranking of #4 while growing Jardiance 480% from 286 TRX to 1661 TRX with continued growth of Tradjenta and Jentadueto. Additionally, I was selected as a Regional Certified Field Trainer, to the Regional Advisory Counsel and asked to continue as the District Computer Expert. Previous responsibilities included promotion of Spiriva, Combivent Respirmat and Pradaxa, Jardiance, Trajenta and Jentadueto. Won District Pradaxa NRX contest obtaining 89% increase in new prescriptions. Successfully launched Jardiance, obtaining 218.30% goal attainment. Made immediate impact with Tradjenta by growing NRX 44.66% in 13 weeks. Additionally, selected as District Computer Expert, responsible for training and assisting the district in efficient use of software and hardware tools. Completed Specialty Sales Leadership Training.

Joined an upstart Biotechnology company, launching a gastro protectant NSAID to Orthopedic Surgeons, Rheumatologists, Neurologists, Podiatrist, Pain Management and Primary Care Physicians. Responsible for formulary placement, hospital formulary placement and pharmacy stocking.

Launched a first in class sleep aide to Sleep Specialist, Pulmonologists, Internal Medicine and Pain Specialist. Additional responsibilities included ensuring retail pharmacy stocking and hospital formulary placement.

Launched Nuvigil and Amrix to Sleep Specialists, Neurologists, Psychiatrists, Pain Management, and Primary Care. Presented and marketed both Nuvigil and Amrix effectively to achieve a national ranking of 1 for Nuvigil and 16 overall for both products. 2009 - Overcame realignment of Amrix to primary product with a territory created for Provigil; to obtain an Amrix ranking of 56 and Presidents Club total ranking of 136. 2008 - Successfully transitioned transfer to new territory ranked 303; to a year end ranking of 92 and a 4th quarter ranking was 31. Management requested continuation of Area Training Manager duties. 2007 -Area Training Manager. Completed Area Management Readiness Program. Selected to Provigil National Marketing Field Advisory Board, Sales Training Market Place Binder Task Force to test market and provide input on new marketing direction and materials, Provigil Growth and Promotional Optimization Program and appointed by executive management to participate in the Sales Force Excellence Solution Team as part of bFocused program. Within bFocused, created and selected as Team Lead for Best Practice Solutions team and member of Sales Training Solutions team. Maintained a Presidents Club ranking of 91.2006 -As a result of successful territory management, business acumen and target identification selected as Area Training Manager. Selected as member of Provigil Field Advisory Board and assisted Marketing in creation and testing of Provigil Sales Aid. Selected as Training advisor to Takeda for their national launch of Provigil for both the 250 and 500 Sales Units. Began 1st quarter with Presidents Club Ranking of 210 and finished with a ranking of 38.2004 - 2005 - In first six months of employment, grew all three products from a ranking of 356 to ranking of 86. Won the 3rd quarter Marketing contest ranked number 1 in the nation for new prescriptions. Continued to grow business to a ranking of 25.

Launched Reminyl, wining Reminyl Superscripts 9 out of 10 months and being selected as Reminyl District Coordinator. Also sold Aciphex, Risperdal and Spornox to Psychiatry, Neurology, Gastroenterology, Internal Medicine and Geriatrics. Elected President of JNJ Pharma Nashville Chapter. Awarded Primary Care Expansion Excellence Award for Outstanding selection and interviewing of candidates. Promoted to Professional Representative. Selected to Johnson and Johnson Management Development Program.

Responsible for calling on Pharmacies, Hospitals, Hospice’s and various specialists including Pain, Dermatologist and Internal Medicine physicians: Oxycontin (CII Analgesic) Spectracef (Antibiotic) Uniphyl (Theophylline) Senokot, Gentlax, Colace, Peri-Colace (Laxatives)

Developed SIU for a multi-state, non-standard, auto insurance company. Responsible for two District Managers, six supervisors and 36 Field Investigators. Created resource manual and training school for investigators and claim personnel. Actively conducted presentations on fraud investigations and fraud awareness around the country to several public and private organizations. Conducted all internal investigations of employee misconduct. Conducted audits of claim offices and staff including Managers for the purpose of increasing office efficiency. Reported directly to CEO.